| Financial Year |
March 31 2023 |
| Monetary Funds |
200,356,949.21 |
| Held-for-trading Financial Assets |
455,595,685.28 |
| Notes Receivable |
-- |
| Accounts Receivable |
46,064,069.79 |
| Advances to Suppliers |
5,178,421.35 |
| Other Receivables |
1,962,229.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,654,177.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,661,907.36 |
| Total Current Assets |
747,503,222.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
111,090.03 |
| Fixed Assetes |
223,077,762.64 |
| Under-construction Projects |
3,149,800.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,796,131.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
505,696.58 |
| Deferred Income Tax Assets |
2,646,980.29 |
| Other Non-Current Assets |
6,119,206.06 |
| Sub-Total of Non-Current Assets |
272,406,667.42 |
| Total Assets |
1,019,909,889.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,120,543.34 |
| Accounts Payable |
27,330,264.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,028,558.48 |
| Taxes Payable |
15,359,578.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,066,696.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
22,498.80 |
| Sub-Total of Current Liabilities |
85,361,838.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,223,104.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,041,436.03 |
| Total Liabilities |
101,403,274.79 |
| Paid-In Capital(Or Share Stock) |
180,000,000.00 |
| Capital Surplus |
169,418,284.73 |
| Surplus Reserve |
80,100,905.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
488,987,424.88 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
918,506,614.98 |
| Owner's Equity（Stockholder's Equity） |
918,506,614.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,019,909,889.77 |
